NEW YORK (GenomeWeb News) – Joshua Sharfstein, who recently was appointed by President Barack Obama to serve as deputy commissioner of the US Food and Drug Administration, this morning takes over as acting FDA commissioner.

Sharfstein will hold that title while confirmation hearings are held for Margaret Hamburg, who was named by Obama to head the agency.

He takes over the interim role from Frank Torti, who has served as acting FDA commissioner since January.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.